Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model
Ying Yuan(The University of Texas MD Anderson Cancer Center), Aixi Yu(Wuhan University), Zonghuan Li(Wuhan University), Daifeng Li(Nanjing University of Posts and Telecommunications), Ai‐Ming Yu(University at Buffalo, State University of New York), Pengcheng Li(North Sichuan Medical University), Yong Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yizhou Li(Wuhan University), Chao Jian(Wuhan University), Wanrong Yi(Wuhan University), Xiang Hu(Wuhan University)
Cited by 3
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Joint Regression Analysis of Correlated Data Using Gaussian Copulas
|Biometrics|2008|207
Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.
|Proceedings of the National Academy of Sciences|1995|196
Mueller Matrix Polarimetry—An Emerging New Tool for Characterizing the Microstructural Feature of Complex Biological Specimen
|Journal of Lightwave Technology|2018|192
RNA therapy: Are we using the right molecules?
|Pharmacology & Therapeutics|2018|172